• The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech

  • 2024/05/15
  • 再生時間： 43 分
  • ポッドキャスト

The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Scott join Liam on this week’s podcast episode. Scott is VP and Global Head of Drug Development at Novotech. Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. In todays session we explore Scott’s origin story, discuss it means to him to put patients first, dive into ways we can deliver trials differently and some of his biggest lessons learned over the years in the clinical trial space and much more!
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Scott join Liam on this week’s podcast episode. Scott is VP and Global Head of Drug Development at Novotech. Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. In todays session we explore Scott’s origin story, discuss it means to him to put patients first, dive into ways we can deliver trials differently and some of his biggest lessons learned over the years in the clinical trial space and much more!
身体的病い・疾患 衛生・健康的な生活
続きを読む 一部表示

The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotechに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。